Delivery Order SPE2DB20D3101-SPE2DB24FQUV5
Award Date
11/17/23
Potential Completion Date
11/20/23
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, from the Defense Logistics Agency (DLA) for the drug Emgality (120 mg/mL pen). The award has a ceiling value of $1,633.21 and an ultimate completion date of October 24, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
This contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,253.40 Firm Fixed Price Delivery Order is for the medication Emgality 120 mg/ml, with a period of performance through July 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,002.72 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of the drug Emgality 120 mg/mL. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA to provide a comprehensive range of pharmaceutical products and medical supplies to military treatment programs and facilities worldwide, with a potential...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,456.59 delivery order contract is for the supply of Emgality 120 mg/ml medication. It is a firm fixed-price contract with a completion date of February 28, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,729.00, is for the provision of the drug Emgality 120 mg/ml. This contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award is for pharmaceutical products and medical supplies delivered to the U.S. Department of Defense (DoD) and other federal healthcare programs. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, which is a subsidiary of the parent company Cencora, Inc. The contract, valued at $1,135.92, is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical. It covers the provision of various prescription...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,729.00, is a delivery order for the medication Emgality 120 mg/ml. The contract has a firm fixed price and an ultimate completion date of January 7, 2025. Amerisourcebergen is the prime contractor on this award and holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,074.80 Firm Fixed Price Delivery Order contract provides the DLA with a variety of medical products, including the drug Emgality 120 mg/ml. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Emgality 300 mg (100 mg x 3 syringes) medication. The $11,407.59 firm fixed price delivery order does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Emgality 120 mg/ml injectable medication to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,002.72 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, on September 26, 2024 with a completion date of September 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop...